Sitemap
January 10, 2015 Articles
Filter by Available Specialty
- Alirocumab meets primary endpoints in ODYSSEY CHOICE trials
- ASTRO presentations highlight advances in glioma, prostate cancer, NSCLC
- Certolizumab pegol may improve clinical outcomes in patients with RA
- Health Canada grants ViaCyte clearance for diabetes clinical trial
- KEYNOTE-013: Pembrolizumab active, safe in pre-treated Hodgkin’s lymphoma
- Latissimus dorsi denervation should include resection of more than 4 cm to prevent twitching
- Obesity not always associated with metabolic problems
- Positive nanoparticle charge increased pulmonary immunization efficacy
- Robust data needed to settle maintenance therapy debate in hematologic malignancies
- University of Colorado School of Medicine receives $1.5 million for orthopedics research
- Yale Cancer Center professor appointed to FDA position